Management Of Amlapitta: A Study On The Efficacy Of Katuka And Sitopala..pdf

The article presents a clinical study evaluating the effectiveness of Katuka (Picrorhiza kurroa) on Amlapitta, a common gastrointestinal (GIT) disorder characterized by symptoms like indigestion, vomiting, nausea, and acid reflux. The study aimed to assess the drug's efficacy both with and without Sitopala (an adjunctive therapy) in two groups of patients.

Methods:

1. Study Design: Randomized, single-blind clinical trial.
2. Participants: 30 patients aged above 12, either gender, diagnosed with Amlapitta based on specific symptoms. Exclusion criteria included peptic ulcers, diabetes, and unwillingness to participate.
3. Treatment:
- Group I: Katuka Mool Churna (2 capsules, 500 mg each) twice daily + Anupana (in water).
- Group II: Katuka Mool Churna + Anupana (in water) plus Sitopala (Mishri, a sweetening agent) and water.
4. Duration: 3 weeks with weekly follow-ups.
5. Dietary Instructions: Patients were advised to avoid spicy foods, alcohol, smoking, and other Pitta-increasing substances.

Assessment Criteria:

Symptoms of Amlapitta were graded on a scale from 0 to 4 based on their severity. The primary outcome was the reduction in symptom scores after treatment.

Results:

Statistically significant improvements were observed in both groups, with better outcomes in Group II (using Katuka + Sitopala). Katuka alone showed effectiveness but Katuka combined with Sitopala led to more pronounced relief from symptoms.

Conclusions:

The study suggests that Katuka, especially when combined with Sitopala, offers a safe and effective single-drug therapy for Amlapitta. This traditional Ayurvedic remedy shows promise in managing this modern-day health problem.